Mounjaro Out-of-Pocket Cost: 8 Real Price Options (2026)

Which Mounjaro price fits you?

Start with the line that sounds like you.

• Type 2 diabetes and a work plan that covers Mounjaro: Lilly's savings card, as little as $25 a fill.
• No coverage for Mounjaro, or no insurance: Lilly's self-pay price, about $500 a month at every dose. It is the simplest route, one flat price shipped by Lilly.
• Paying cash, mainly for weight loss: Zepbound at Lilly's self-pay price, about $300 to $450 a month by dose.
• Cheapest cash start, brand not required: compounded tirzepatide from Mochi Health, about $170 to $280 a month by dose.
• On Medicare with type 2 diabetes: your Part D drug plan, which caps what you pay at $2,100 a year in 2026.

The 8 Mounjaro price options, one by one

Lilly Savings Card: who pays $25 and who pays $500?

Lilly's Mounjaro savings card is the strongest discount for people with work or private insurance. It has two very different tiers. Which one you get depends on one question: does your plan cover Mounjaro?

• $25 tier: your work or private plan covers Mounjaro. You can pay as little as $25 a fill, even for a 3-month supply. The card takes off up to $150 a month, and up to $1,950 a year.
• About $500 tier: you have work or private insurance, but your plan does not cover Mounjaro. You pay about $500 a month. The card saves up to $8,411 a year.
• Not eligible: Medicare, Medicaid, VA, TRICARE and other government plans. The card ends December 31, 2026.

The fine print matters. The card works only for an FDA-approved use, and Mounjaro is approved for type 2 diabetes. A prescription written for weight loss alone does not qualify.

A 3-month fill can save the most. Your insurer and pharmacy must allow it, so ask both before your doctor writes it.

LillyDirect Mounjaro: about $500 a month at any dose

Lilly now sells Mounjaro directly to people paying cash, through its LillyDirect pharmacy. The self-pay price starts at $499 a month for every dose, from 2.5 mg to 15 mg.

Lilly says it is open to people with no insurance. It is also open to people whose plan does not cover Mounjaro, government plans included. You need a prescription, and your doctor sends it to LillyDirect.

This is the same price as the savings card's no-coverage tier. The difference is who can use it. The card needs a work or private plan, while LillyDirect does not.

LillyDirect Zepbound: the cheaper brand-name option for cash payers

Lilly also sells Zepbound, the same drug as Mounjaro, to people paying cash. LillyDirect sells both the KwikPen and the single-dose vial at the same self-pay prices:

• 2.5 mg starter dose: about $300 a month
• 5 mg: about $400 a month
• 7.5 mg up to 15 mg: about $450 a month

From 7.5 mg up, you must refill within 45 days of your last delivery to keep that price. Miss it and a 7.5 mg fill costs about $500. Higher doses cost about $700. Set a reminder.

Since March 2026, you can also fill the Zepbound KwikPen at these prices at a retail pharmacy, with Lilly's free self-pay card. You cannot bill insurance for these fills.

Zepbound costs less than Mounjaro's own self-pay price at every dose. It is approved for weight management, not diabetes, so it fits when weight is a reason for treatment. The tirzepatide cost breakdown compares both brands side by side. Mounjaro vs Zepbound explains the differences.

Mochi Health: compounded tirzepatide, about $170 to $280 a month

Compounded tirzepatide is mixed by a pharmacy from the same active ingredient. It is not FDA-approved. Mochi charges a $79 monthly membership plus a medicine fee that rises with your dose.

Since August 2026, the medicine costs about $90 a month at the lowest dose. At the top dose, it costs about $200.

• Month to month: about $170 a month at the lowest dose, about $280 at the top
• First month: about $90, because new members get the membership free. The offer is not available in every state.
• Prepaid year: the membership drops to $49 a month, so about $140 a month at the lowest dose

The membership and the medicine are billed as two separate subscriptions. Canceling one does not cancel the other, a common complaint in reviews. Mochi now works with more than 30 partner pharmacies, so the medicine price can vary a little.

Eli Lilly sued Mochi over how it marketed compounded tirzepatide. An earlier version of the complaint was dismissed. In April 2026, a federal judge let Lilly's revised claims go forward, and the case is ongoing. Read our full Mochi Health review.

Fridays: compounded tirzepatide, about $240 to $390 a month

Fridays charges about $240 a month on its annual plan, paid upfront for 12 months. Month to month, it costs about $390.

Both plans include online provider visits, a one-on-one dietitian, group coaching and a fitness app, with no separate membership. Fridays' terms say fees are not refunded if you cancel mid-plan. Its Better Business Bureau profile lists many unanswered complaints, mostly about refunds and late shipments. Read the Fridays review before enrolling.

Henry Meds: a tirzepatide tablet, billed every 3 months

Henry Meds sells compounded tirzepatide as a tablet that dissolves in your mouth. It costs about $350 a month, billed as a 3-month supply.

The price includes visits, supplies and shipping, with no membership fee. Henry says its price varies with your dose, and it does not publish its higher-dose prices. Ask for your dose's price before you sign up. See the Henry Meds review for the full picture.

GoodRx coupon

GoodRx is a free coupon, not insurance. For Mounjaro, it barely helps. With a coupon, expect about $1,090 a month, just under the list price. Prices change by pharmacy and ZIP code. Check GoodRx for your area before you fill.

List price, with no discount

Lilly's list price for Mounjaro is about $1,110 for a 28-day carton of four pens. The list price is the catalog price Lilly charges wholesalers. Without a coupon, many pharmacies charge more than that.

The price is the same at all six doses, from 2.5 mg to 15 mg. Lilly prices Mounjaro by the carton, not by the milligram.

Mounjaro vs Zepbound: same drug, very different price path

Mounjaro and Zepbound are the same medicine. Both contain tirzepatide, made by Eli Lilly, in the same doses. The only difference is their FDA approval.

Mounjaro was approved in 2022 for type 2 diabetes. Zepbound was approved in 2023 for long-term weight management.

That one difference shapes every cost. Insurance covers medicines by approved use, not by molecule. A plan may cover Mounjaro for diabetes but deny the same drug, as Zepbound, when obesity is the only reason.

For women in perimenopause, weight and blood sugar problems often overlap. Which approved use fits you is worth working out with your provider. If weight is the main goal and you pay cash, Zepbound is usually the better financial choice.

Is compounded tirzepatide legal in 2026?

Only through a narrow path. The FDA declared the tirzepatide shortage over in December 2024. Its grace period ended on February 18, 2025, for 503A pharmacies, which make drugs for individual patients. It ended on March 19, 2025, for 503B outsourcing facilities, which make larger batches.

A 503A pharmacy may still make tirzepatide for one patient when the prescriber documents a need the brand cannot meet, such as an allergy to an inactive ingredient. Lower cost alone does not count.

In April 2026, the FDA also proposed not adding tirzepatide to the list of raw ingredients 503B facilities may use. No final decision has been announced.

Eli Lilly has sued several telehealth companies over compounded tirzepatide. Ask any provider which pharmacy makes your medicine and how your prescription is documented. Compounded Mounjaro covers the rules in more detail.

Does insurance or Medicare cover Mounjaro for weight loss?

Almost certainly not, if weight loss is the reason on the prescription. Mounjaro is approved for type 2 diabetes, and when a plan covers it, coverage is tied to that use. Most commercial insurers deny Mounjaro written for weight management.

Medicare Part D, Medicare's drug coverage, cannot cover drugs used only for weight loss. It can cover Mounjaro for a member with type 2 diabetes if it is on the plan's drug list. In 2026, Part D caps what you pay for covered drugs at $2,100 a year.

If your Part D plan does not cover Mounjaro, Lilly says its self-pay price may still be open to you. The savings card is not.

Since July 1, 2026, Medicare's GLP-1 Bridge gives eligible Part D members the Zepbound KwikPen for weight loss at $50 a month, through December 31, 2027. Mounjaro is not part of the Bridge.

If weight management is your main goal, ask your provider about Zepbound. It carries the weight-loss approval. That opens on-label insurance coverage, the Bridge on Medicare, and Lilly's lower self-pay prices. The GLP-1 cost overview compares costs across the whole category.

Can you get Mounjaro free?

Not right now. Lilly Cares is Lilly's charity that gives free medicine to some people with low incomes. Its current list of medicines does not include Mounjaro or Zepbound.

If you have type 2 diabetes and no coverage, the list does include Trulicity. It is an older weekly shot from the same drug family. Ask your doctor whether it fits you.

What does Mounjaro cost per year?

Mounjaro and Zepbound come in 28-day cartons, so a year is 13 fills, not 12. The compounded programs bill monthly. The totals below follow the usual dose steps where the price changes with the dose.

• Savings card, plan covers Mounjaro: as little as about $325 a year on monthly fills, less with 3-month fills
• Mochi Health, prepaid year: about $1,670 at the lowest dose all year. About $2,975 at the top dose.
• Medicare Part D, for diabetes: no more than $2,100 a year out of pocket
• Fridays, prepaid year: about $2,880
• Henry Meds tablets: from about $4,190 a year at the starting price
• LillyDirect Zepbound: about $5,090 in the first year if you stay at 5 mg. About $5,640 if you step up to 7.5 mg or more.
• Mounjaro self-pay or the card's no-coverage tier: about $6,490 a year at any dose
• GoodRx coupon: about $14,170 a year
• List price, no discount: about $14,460 a year

Paying Mochi month to month instead costs about $1,950 in the first year at the lowest dose, with the free first month.

The gap between the cheapest insured path and the list price is more than $14,000 a year. That is why checking your coverage and card eligibility before the first fill matters so much. The cheapest tirzepatide providers compares compounded and brand prices side by side.